David Sinclair is a biologist and professor of genetics at Harvard Medical School. He is a renowned researcher in the field of aging and longevity, and his work focuses on understanding the biological mechanisms that contribute to aging and age-related diseases, as well as developing interventions to delay or prevent these conditions.
Sinclair’s research has made significant contributions to the field of aging and has led to the discovery of several key genes and pathways involved in aging and disease. He is particularly interested in the role of sirtuins, a family of proteins that regulate cellular metabolism and play a key role in aging and age-related diseases.
Sinclair is also a co-founder of several biotech companies, including Sirtris Pharmaceuticals, which was acquired by GlaxoSmithKline in 2008, and MetroBiotech, which focuses on developing therapies to treat age-related diseases.
Sinclair has received numerous awards and honors for his contributions to the field of aging research, including being named one of Time magazine’s “100 Most Influential People in the World” in 2014. He is also the author of the book “Lifespan: Why We Age―and Why We Don’t Have To,” which explores the latest research on aging and longevity and offers insights into how we can live healthier, longer lives.
